CR3 KEYLESS SPLIT SAMPLE CUP(OPI-BZO)

Enzyme Immunoassay, Opiates

Guangzhou Wondfo Biotech Co., Ltd.

The following data is part of a premarket notification filed by Guangzhou Wondfo Biotech Co., Ltd. with the FDA for Cr3 Keyless Split Sample Cup(opi-bzo).

Pre-market Notification Details

Device IDK140089
510k NumberK140089
Device Name:CR3 KEYLESS SPLIT SAMPLE CUP(OPI-BZO)
ClassificationEnzyme Immunoassay, Opiates
Applicant Guangzhou Wondfo Biotech Co., Ltd. 504 EAST DIAMOND AVE. SUITE F Gaithersburg,  MD  20878
ContactJoe Shia
CorrespondentJoe Shia
Guangzhou Wondfo Biotech Co., Ltd. 504 EAST DIAMOND AVE. SUITE F Gaithersburg,  MD  20878
Product CodeDJG  
CFR Regulation Number862.3650 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-01-14
Decision Date2014-04-08
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.